Pro rata oversubscription allocation and refund of excess
Company: Core Scientific
The claim, verbatim
Because the ERO is capped at $55 million, oversubscriptions will be allocated pro rata and excess payments will be returned to participants per the Rights Offering Procedures.
Source (primary)
core-scientific 8-K exhibit (d109221dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-15)Live source ↗
Quote: “Any excess payments made by ERO participants that exercised oversubscription rights, after giving effect to the proration and the $55 million maximum offering amount, will be returned to such ERO participants”
How we checked this
Checked on November 16, 2026. The cited source supports every part of this claim.
The release states that, because of the $55 million cap, oversubscriptions will be prorated and excess payments returned under the company's Rights Offering Procedures.
Confirmed in the source:
- The Equity Rights Offering is capped at $55 million
- Oversubscriptions will be allocated pro rata among participants who exercised oversubscription rights
- Excess payments will be returned to participants in accordance with the Rights Offering Procedures
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312524004018/d109221dex992.htm) in full (6,982 characters, retrieved November 15, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d109221dex992.htm)
Quote: “Any excess payments made by ERO participants that exercised oversubscription rights, after giving effect to the proration and the $55 million maximum offering amount, will be returned to such ERO participants”